miércoles, 2 de octubre de 2024

Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00320-X/fulltext?dgcid=hubspot_update_feature_updatealerts_laneur&utm_campaign=update-laneur&utm_medium=email&_hsenc=p2ANqtz---WGHEPlTBT9w7FJ1VoMfk_b77NP3ZLAWkvjth5oI-Bjt2HAC12oKAaXIB9510denQPNY5RHoyf15ojh-jNEzor23Bug&_hsmi=327146766&utm_content=327101233&utm_source=hs_email

No hay comentarios:

Publicar un comentario